Carotenoid oxidative/degradative products and their biological activities

Carotenoids in Health and Disease

Volumn , Issue , 2004, Pages 313-336

  Wang, Xiang Dong ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971281017     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (115)

1. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 1996; 10: 690-701.
2. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
3. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-1570.
4. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Cherniack MG, Brodkin CA, Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-1559.
5. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155.
6. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of longterm supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
7. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women’s Health Study. J Natl Cancer Inst 1999; 91: 2102-2106.
8. Williams AW, Boileau TW, Zhou JR, Clinton SK, Erdman JW Jr. Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J Nutr 2000; 130: 728-732.
9. Feskanich D, Ziegler RG, Michaud DS, Giovannucci EL, Speizer FE, Willett WC, Colditz GA. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92: 1812-1823.
10. Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000; 72: 990-997.
11. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-1888.
12. Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, Bean J, Zheng T, Cooper D, Friedman C, Goodwin WJ Jr. Randomized trial of supplemental betacarotene to prevent second head and neck cancer. Cancer Res 2001; 61: 1457-1463.
13. De Flora S, Bagnasco M, Vainio H. Modulation of genotoxic and related effects by carotenoids and vitamin A in experimental models: mechanistic issues. Mutagenesis 1999; 14: 153-172.
14. Furukawa F, Nishikawa A, Kasahara K, Lee IS, Wakabayashi K, Takahashi M, Hirose M. Inhibition by beta-carotene of upper respiratory tumorigenesis in hamsters receiving diethylnitrosamine followed by cigarette smoke exposure. Jpn J Cancer Res 1999; 90: 154-161.
15. Ponnamperuma RM, Shimizu Y, Kirchhof SM, De Luca LM. Beta-carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice. Nutr Cancer 2000; 37: 82-88.
16. Bishayee A, Sarkar A, Chatterjee M. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamineinitiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid. Nutr Cancer 2000; 37: 89-98.
17. Olson JA, Hayaishi O. The enzymatic cleavage of beta-carotene into vitamin A by soluble enzymes of rat liver and intestine. Proc Natl Acad Sci U S A 1965; 54: 1364-1370.
18. Wang XD, Krinsky NI. The bioconversion of beta-carotene into retinoids. Subcell Biochem 1998; 30: 159-180.
19. Wyss A, Wirtz G, Woggon W, Brugger R, Wyss M, Friedlein A, Bachmann H, Hunziker W. Cloning and expression of beta, beta-carotene 15, 150-dioxygenase. Biochem Biophys Res Commun 2000; 271: 334-336.
20. von Lintig J, Wyss A. Molecular analysis of vitamin A formation: cloning and characterization of beta-carotene 15, 150-dioxygenases. Arch Biochem Biophys 2001; 385: 47-52.
21. Leuenberger MG, Engeloch-Jarret C, Woggon WD. The reaction mechanism of the enzyme-catalyzed central cleavage of beta-carotene to retinal. Angew Chem Int Ed Engl 2001; 40: 2613-2617.
22. Lindqvist A, Andersson S. Biochemical properties of purified recombinant human β-carotene 15, 150-monooxygenase. J Biol Chem 2002; 277: 23942-23948.
23. Glover J. The conversion of beta-carotene into vitamin A. Vitam Horm 1960; 18: 371-386.
24. Sharma RV, Mathur SN, Dmitrovskii AA, Das RC, Ganguly J. Studies on the metabolism of beta-carotene and apo-beta-carotenoids in rats and chickens. Biochim Biophys Acta 1976; 486: 183-194.
25. Sharma RV, Mathur SN, Ganguly J. Studies on the relative biopotencies and intestinal absorption of different apo-beta-carotenoids in rats and chickens. Biochem J 1976; 158: 377-383.
26. Wang XD, Tang GW, Fox JG, Krinsky NI, Russell RM. Enzymatic conversion of beta-carotene into beta-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch Biochem Biophys 1991; 285: 8-16.
27. Tang GW, Wang XD, Russell RM, Krinsky NI. Characterization of beta-apo-13- carotenone and beta-apo-140-carotenal as enzymatic products of the excentric cleavage of beta-carotene. Biochemistry 1991; 30: 9829-9834.
28. Wang XD, Marini RP, Hebuterne X, Fox JG, Krinsky NI, Russell RM. Vitamin E enhances the lymphatic transport of beta-carotene and its conversion to vitamin A in the ferret. Gastroenterology 1995; 108: 719-726.
29. Hebuterne X, Wang XD, Smith DE, Tang G, Russell RM. In vivo biosynthesis of retinoic acid from beta-carotene involves and excentric cleavage pathway in ferret intestine. J Lipid Res 1996; 37: 482-492.
30. Liu C, Wang XD, Russell RM. Biosynthesis of retinoic acid from beta-apo-140- carotenal in ferret in vivo. J Nutr Biochem 1997; 8: 652-657.
31. Wang XD, Krinsky NI, Marini RP, Tang G, Yu J, Hurley R, Fox JG, Russell RM. Intestinal uptake and lymphatic absorption of beta-carotene in ferrets: a model for human beta-carotene metabolism. Am J Physiol 1992; 263: G480-G486.
32. Kiefer C, Hessel S, Lampert JM, Vogt K, Lederer MO, Breithaupt DE, von Lintig J. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J Biol Chem 2001; 276: 14110-14116.
33. Hu K, Liu C, Krinsky NI, Russell RM, Wang XD. Cloning and characterization of carotene 90, 100-monooxygenase in ferrets (submitted).
34. Napoli JL, Race KR. Biogenesis of retinoic acid from beta-carotene. Differences between the metabolism of beta-carotene and retinal. J Biol Chem 1988; 263: 17372-17377.
35. Wang XD, Krinsky NI, Tang GW, Russell RM. Retinoic acid can be produced from excentric cleavage of beta-carotene in human intestinal mucosa. Arch Biochem Biophys 1992; 293: 298-304.
36. Wang XD, Russell RM, Liu C, Stickel F, Smith DE, Krinsky NI. Beta-oxidation in rabbit liver in vitro and in the perfused ferret liver contributes to retinoic acid biosynthesis from beta-apocarotenoic acids. J Biol Chem 1996; 271: 26490-26498.
37. Folmani Y, Russell RM, Tang GW, Wolf DG. Rabbits fed on beta-carotene have higher serum levels of all-trans retinoic acid than those receiving no beta-carotene. Br J Nutr 1989; 62: 195-201.
38. Wang XD, Krinsky NI, Russell RM. Retinoic acid regulates retinol metabolism via feedback inhibition of retinol oxidation and stimulation of retinol esterification in ferret liver. J Nutr 1993; 123: 1277-1285.
39. Khachik F, Beecher GR, Smith JC Jr. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem Suppl 1995; 22: 236-246.
40. Khachik F, Spangler CJ, Smith JC Jr, Canfield LM, Steck A, Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 1997; 69: 1873-1881.
41. Liu C, Lian F, Smith DE, Russell RM, Wang XD. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulinlike growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003; 63: 3138-3144.
42. Kim SJ, Nara E, Kobayashi H, Terao J, Nagao A. Formation of cleavage products by autoxidation of lycopene. Lipids 2001; 36: 191-199.
43. Nara E, Hayashi H, Kotake M, Miyashita K, Nagao A. Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr Cancer 2001; 39: 273-283.
44. Ben-Dor A, Nahum A, Danilenko M, Giat Y, Stahl W, Martin HD, Emmerich T, Noy N, Levy J, Sharoni Y. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch Biochem Biophys 2001; 391: 295-302.
45. Hanusch M, Stahl W, Schulz WA, Sies H. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch Biochem Biophys 1995; 317: 423-428.
46. Nikawa T, Schulz WA, van den Brink CE, Hanusch M, van der Saag P, Stahl W, Sies H. Efficacy of all-trans-beta-carotene, canthaxanthin, and all-trans-, 9-cis-, and 4-oxoretinoic acids in inducing differentiation of an F9 embryonal carcinoma RAR beta-lacZ reporter cell line. Arch Biochem Biophys 1995; 316: 665-672.
47. Pijnappel WW, Hendriks HF, Folkers GE, van den Brink CE, Dekker EJ, Edelenbosch C, van der Saag PT, Durston AJ. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 1993; 366: 340-344.
48. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
49. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001; 1: 181-193.
50. Wang XD, Krinsky NI, Benotti PN, Russell RM. Biosynthesis of 9-cis-retinoic acid from 9-cis-β-carotene in human intestinal mucosa in vitro. Arch Biochem Biophys 1994; 313: 150-155.
51. Liu C, Wang XD, Bronson RT, Smith DE, Krinsky NI, Russell RM. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 2000; 21: 2245-2253.
52. Prakash P, Liu C, Hu KQ, Krinsky NI, Russell RM, Wang XD. Effects of betacarotene, beta-apo-140-carotenoic acid and benzo[a]pyrene on retinoic acid receptor b expression and growth of normal human bronchial epithelial cells. J Nutr 2004; 134 (in press).
53. Hu XM, White KM, Jacobsen NE, Mangelsdorf DJ, Canfield LM. Inhibition of growth and cholesterol synthesis in breast cancer cells by oxidation products of beta-carotene. Journal Nutrition Biochemistry 1998; 9: 567-574.
54. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D, Chambon P. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 2000; 407: 633-636.
55. Suzuki T, Matsui M, Murayama A. Biological activity of (all-E)-beta-apo-120- carotenoic acid and the geometrical isomers on human acute promyelocytic leukemia cell line HL-60. J Nutr Sci Vitaminol (Tokyo) 1995; 41: 575-585.
56. Winum JY, Kamal M, Defacque H, Commes T, Chavis C, Lucas M, Marti J, Montero JL. Synthesis and biological activities of higher homologues of retinoic acid. Farmaco 1997; 52: 39-42.
57. Tibaduiza EC, Fleet JC, Russell RM, Krinsky NI. Excentric cleavage products of beta-carotene inhibit estrogen receptor positive and negative breast tumor cell growth in vitro and inhibit activator protein-1-mediated transcriptional activation. J Nutr 2002; 132: 1368-1375.
58. Stahl W, Von Laar J, Martin HD, Emmerich T, Sies H. Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 2000; 373: 271-274.
59. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? Br J Urol Int 2001; 87: 814-820.
60. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomark Prev 2002; 11: 852-861.
61. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 2000; 36: 101-111.
62. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472-1489.
63. Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 1999; 51 (suppl 3): 34-41.
64. Rechler M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what’s IGF got to do with it? Endocrinology 1997; 138: 2645-2647.
65. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000; 275: 33607-33613.
66. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993; 268: 14964-14971.
67. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999; 91: 151-156.
68. London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK, Yu MC. Insulinlike growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst 2002; 94: 749-754.
69. Hochscheid R, Jaques G, Wegmann B. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. J Endocrinol 2000; 166: 553-563.
70. Salgo MG, Cueto R, Winston GW, Pryor WA. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999; 26: 162-173.
71. Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, Legator MS. Cocarcinogenic effect of beta-carotene. Nature 1999; 398: 760-761.
72. Liu C, Russell RM, Wang XD. Exposing ferrets to cigarette smoke and a pharmacological dose of beta-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr 2003; 133: 173-179.
73. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91: 60-66.
74. Siems W, Sommerburg O, Schild L, Augustin W, Langhans CD, Wiswedel I. Beta-carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J 2002; 16: 1289-1291.
75. þ-ATPase. Free Radic Res 2000; 33: 427-435.
76. Perocco P, Paolini M, Mazzullo M, Biagi GL, Cantelli-Forti G. Beta-carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro. Mutat Res 1999; 440: 83-90.
77. Lowe GM, Booth LA, Young AJ, Bilton RF. Lycopene and beta-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic Res 1999; 30: 141-151.
78. Yeh S, Hu M. Antioxidant and pro-oxidant effects of lycopene in comparison with beta-carotene on oxidant-induced damage in Hs68 cells. J Nutr Biochem 2000; 11: 548-554.
79. Jetten AM, George MA, Smits HL, Vollberg TM. Keratin 13 expression is linked to squamous differentiation in rabbit tracheal epithelial cells and down-regulated by retinoic acid. Exp Cell Res 1989; 182: 622-634.
80. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996; 10: 1031-1039.
81. Houle B, Rochette-Egly C, Bradley WE. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993; 90: 985-989.
82. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Hong WK, Lotan R. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999; 91: 1317-1321.
83. Dietary Reference Intakes: Vitamin A, Vitamin K and Micronutrients. Washington DC: National Academy Press, 2001.
84. Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, Zhang ZF. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomark Prev 2001; 10: 749-756.
85. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM, Greenberg RS, Hoover RN, Hayes RB, Ziegler RG. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 2002; 155: 1023-1032.
86. Schmitz HH, Poor CL, Wellman RB, Erdman JW Jr. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991; 121: 1613-1621.
87. Hininger IA, Meyer-Wenger A, Moser U, Wright A, Southon S, Thurnham D, Chopra M, van Den Berg H, Olmedilla B, Favier AE, Roussel AM. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr 2001; 20: 232-238.
88. Obermueller-Jevic UC, Espiritu I, Corbacho AM, Cross CE, Witschi H. Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol Sci 2002; 69: 23-29.
89. Cohen LA. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med (Maywood) 2002; 227: 864-868.
90. Kim DJ, Takasuka N, Nishino H, Tsuda H. Chemoprevention of lung cancer by lycopene. Biofactors 2000; 13: 95-102.
91. Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z, Cohen LA. Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett 2001; 164: 1-6.
92. Gradelet S, Leclerc J, Siess MH, Astorg PO. Beta-apo-80-carotenal, but not betacarotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996; 26: 909-919.
93. Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, Heinonen OP. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997; 66: 366-372.
94. Kessova IG, Leo MA, Lieber CS. Effect of beta-carotene on hepatic cytochrome P-450 in ethanol-fed rats. Alcohol Clin Exp Res 2001; 25: 1368-1372.
95. Leo MA, Kim C-I, Lowe N, Lieber CS. Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992; 15: 883-891.
96. Liu C, Russell RM, Seitz HK, Wang XD. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 2001; 120: 179-189.
97. Chung J, Chavez PR, Russell RM, Wang XD. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats. Oncogene 2002; 21: 1539-1547.
98. Chung J, Liu C, Smith DE, Seitz HK, Russell RM, Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis 2001; 22: 1213-1219.
99. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210.
100. Mayne ST, Handelman GJ, Beecher G. Beta-carotene and lung cancer promotion in heavy smokers-a plausible relationship? J Natl Cancer Inst 1996; 88: 1513-1515.
101. Arora A, Willhite CA, Liebler DC. Interactions of beta-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 2001; 22: 1173-1178.
102. Wang XD, Russell RM. Procarcinogenic and anticarcinogenic effects of betacarotene. Nutr Rev 1999; 57: 263-272.
103. Bohm FE, R. Land, E.J. McGarvey, D.J. Truscott T.G. Carotenoids enhance vitamin E antioxidant efficiency. J Am Chem Soc 1997; 119: 621-622.
104. Bohm F, Edge R, McGarvey DJ, Truscott TG. Beta-carotene with vitamins E and C offers synergistic cell protection against NOx. FEBS Lett 1998; 436: 387-389.
105. Palozza P, Krinsky NI. Beta-carotene and alpha-tocopherol are synergistic antioxidants. Arch Biochem Biophys 1992; 297: 184-187.
106. Yeum KJ, dos Anjos Ferreira AL, Smith D, Krinsky NI, Russell RM. The effect of alpha-tocopherol on the oxidative cleavage of beta-carotene. Free Radic Biol Med 2000; 29: 105-114.
107. Palozza P, Serini S, Torsello A, Di Nicuolo F, Piccioni E, Ubaldi V, Pioli C, Wolf FI, Calviello G. Beta-carotene regulates NF-kappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J Nutr 2003; 133: 381-388.
108. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health 1989; 79: 158-162.
109. Tribble DL, Giuliano LJ, Fortmann SP. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr 1993; 58: 886-890.
110. Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001; 292: 2083-2086.
111. Yong LC, Brown CC, Schatzkin A, Dresser CM, Slesinski MJ, Cox CS, Taylor PR. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey. Am J Epidemiol 1997; 146: 231-243.
112. Howard DJ, Ota RB, Briggs LA, Hampton M, Pritsos CA. Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation. Cancer Epidemiol Biomark Prev 1998; 7: 981-988.
113. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996; 56: 1291-1295.
114. Chongviriyaphan N, Liu C, Lipman R, Russell RM, Wang XD. Beta-carotene in the presence of alpha-tocopherol and vitamin C pretects against lung squamous metaplasia in ferrets exposed to tobacco smoke (manuscript in preparation).
115. Wang XD. Mechanistic understanding of potential adverse effects of beta-carotene supplementation. In: Eisenbrand G, eds. Functional Food: Safety Aspects. Weinheim: Wiley-VCH, 2004: 189-215.